Omnicare Swings To 2Q Loss On Charges, Discontinued Operations

Date : 07/26/2011 @ 8:20AM
Source : Dow Jones News
Stock : (OCR)
Quote : 97.9  0.0 (0.00%) @ 2:05AM

Omnicare Swings To 2Q Loss On Charges, Discontinued Operations

Omnicare Inc. (OCR) swung to a second-quarter loss on litigation-related charges and a sharply wider loss at its discontinued operations, which included the contract-service business that the company sold in April.

Adjusted profit from continuing operations and revenue beat analysts' expectations.

The provider of drugs to nursing homes and assisted-living centers has seen its bottom line hurt by litigation charges and other expenses in recent quarters. Omnicare has been working to recover from turmoil that apparently led to a management upheaval last year. The company has been trying to build up its drug-distribution business and shed noncore operations.

Omnicare reported a loss of $1.5 million, or a penny a share, from a year-earlier profit of $11.6 million, or 10 cents a share. Excluding litigation-related charges, earnings from continuing operations were up at 50 cents from 49 cents.

Revenue increased 4.3% to $1.56 billion.

Analysts polled by Thomson Reuters most recently forecast earnings of 49 cents on revenue of $1.53 billion.

Gross margin edged down to 21.6% from 21.9%.

Shares of Omincare, which affirmed its 2011 guidance, closed Monday at $30.39 and were inactive premarket. The stock is up 59% from a two-year low in August following the abrupt departure of its management team.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.